research grade retatrutide GLP-3 RETA Retatrutide Triple Agonist (GLP-1/GIP/GCG) |

Traditionally, compounding is used for patients who are allergic to a medication additive or who need a liquid form instead of a pill not for patients who could take an existing name-brand medication

It can be administered on any day of the week, at any time

Interaction with existing medical conditions or therapies

For patients managing type 2 diabetes and considering weight loss strategies, we offer personalized consultations to explore the potential off-label use of Tirzepatide

However, WADA is currently monitoring and evaluating the use of GLP-1 agonists by athletes to determine if they should be prohibited in the future

Floridas SB 860 targets weight-loss drugs specifically, requiring you to certify that your API is identical to the approved drug and sourced from a facility inspected within the last two years